Somatic RHOA mutation in angioimmunoblastic T cell lymphoma

Area of Science:

• Hematology
• Molecular Biology
• Oncology

Background:

• Angioimmunoblastic T cell lymphoma (AITL) is a peripheral T cell lymphoma with characteristic lymphadenopathy and autoimmune features.
• While mutations in TET2, IDH2, and DNMT3A are known in AITL, the specific molecular drivers remain unclear.

Purpose of the Study:

• To investigate the specific molecular pathogenesis of Angioimmunoblastic T cell lymphoma.
• To identify novel mutations contributing to AITL development.

Main Methods:

• Somatic mutation analysis of AITL patient samples.
• Functional assays to assess the impact of identified mutations on protein activity.

Main Results:

• Somatic mutations in RHOA, specifically encoding a p.Gly17Val alteration, were identified in 68% of AITL samples.
• All RHOA p.Gly17Val mutated samples also harbored TET2 mutations.
• The RHOA p.Gly17Val mutant exhibited impaired GTP binding and inhibited wild-type RHOA function, with mutations primarily in tumor cells.

Conclusions:

• Impaired RHOA function, resulting from specific mutations, plays a significant role in AITL pathogenesis.
• The combined effect of preceding TET2 dysfunction and subsequent RHOA impairment contributes to AITL development.